{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:19:19Z","timestamp":1793834359510,"version":"4.6.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802726"],"award-info":[{"award-number":["81802726"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Long intergenic non-protein coding RNA 520 (LINC00520), a novel identified lncRNA, has been shown to modulate the malignant phenotype of tumor cells in some malignant tumors. However, the exact role and molecular mechanism of LINC00520 in malignant melanoma has not been studied.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The expression of LINC00520 in melanoma tissues were detected by using RNA-seq analysis and qRT-PCR. Melanoma cases from the public databases (The Cancer Genome Atlas (TCGA), GEO#GSE15605, GEO#GSE34460 and GEO#GSE24996) were included in this study. CCK-8 assay, EdU assay, transwell and scratch wound assay were used to explore the role of LINC00520 in melanoma cells. Luciferase reporter assays, MS2-RIP, RNA pull-down and RNA-ChIP assay were used to demonstrate the molecular biological mechanism of LINC00520 in melanoma.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>We found that LICN00520 was found to be overexpressed in melanoma tissue. High expression of LICN00520 is a risk factor for the prognosis of melanoma patients. LINC00520 promotes the proliferation, invasion and migration of melanoma cells. LICN00520 exerted its oncogenic role by competitive binding miR-125b-5p to promote Eukaryotic initiation factor 5A2 (EIF5A2) expression. We also showed that LICN00520 promotes the growth and metastasis of melanoma in vivo through regulating miR-125b-5p\/EIF5A2 axis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>All results elucidated the role and molecular mechanism of LINC00520 in the malignant development of melanoma. LINC00520, a new oncogene in melanoma, maybe serve as a survival biomarkers or therapeutic target for melanoma patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13046-020-01599-7","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T07:02:43Z","timestamp":1590649363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Long non-coding RNA LINC00520 promotes the proliferation and metastasis of malignant melanoma by inducing the miR-125b-5p\/EIF5A2 axis"],"prefix":"10.1186","volume":"39","author":[{"given":"Wenkang","family":"Luan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongru","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"issue":"7","key":"1599_CR1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/exd.12400","volume":"23","author":"NK Haass","year":"2014","unstructured":"Haass NK, Schumacher U. Melanoma never says die. Exp Dermatol. 2014;23(7):471\u20132. https:\/\/doi.org\/10.1111\/exd.12400.","journal-title":"Exp Dermatol"},{"issue":"1","key":"1599_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21387.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"1599_CR3","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1158\/1541-7786.MCR-17-0528","volume":"16","author":"C Kosnopfel","year":"2018","unstructured":"Kosnopfel C, Sinnberg T, Sauer B, Busch C, Niessner H, Schmitt A, et al. YB-1 expression and phosphorylation regulate Tumorigenicity and invasiveness in melanoma by influencing EMT. Mol Cancer Res. 2018;16(7):1149\u201360. https:\/\/doi.org\/10.1158\/1541-7786.MCR-17-0528.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"1599_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332. https:\/\/doi.org\/10.3322\/caac.21338.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"1599_CR5","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1101\/gad.191999.112","volume":"26","author":"H Tsao","year":"2012","unstructured":"Tsao H, Chin L, Garraway LA, Fisher DE. Melanoma: from mutations to medicine. Genes Dev. 2012;26(11):1131\u201355. https:\/\/doi.org\/10.1101\/gad.191999.112.","journal-title":"Genes Dev"},{"issue":"4","key":"1599_CR6","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.bbamcr.2016.01.025","volume":"1863","author":"J Paluncic","year":"2016","unstructured":"Paluncic J, Kovacevic Z, Jansson PJ, Kalinowski D, Merlot AM, Huang ML, et al. Roads to melanoma: key pathways and emerging players in melanoma progression and oncogenic signaling. Biochim Biophys Acta. 2016;1863(4):770\u201384.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"1599_CR7","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","volume":"43","author":"KC Wang","year":"2011","unstructured":"Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43(6):904\u201314. https:\/\/doi.org\/10.1016\/j.molcel.2011.08.018.","journal-title":"Mol Cell"},{"issue":"4","key":"1599_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt AM, Chang HY. Long noncoding RNAs in Cancer pathways. Cancer Cell. 2016;29(4):452\u201363. https:\/\/doi.org\/10.1016\/j.ccell.2016.03.010.","journal-title":"Cancer Cell"},{"issue":"12","key":"1599_CR9","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1158\/1541-7786.MCR-18-0087","volume":"16","author":"S Lingadahalli","year":"2018","unstructured":"Lingadahalli S, Jadhao S, Sung YY, Chen M, Hu L, Chen X, et al. Novel lncRNA LINC00844 regulates prostate Cancer cell migration and invasion through AR signaling. Molecular cancer research : MCR. 2018;16(12):1865\u201378. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0087.","journal-title":"Molecular cancer research : MCR"},{"issue":"11","key":"1599_CR10","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/s41419-019-2090-3","volume":"10","author":"W Luan","year":"2019","unstructured":"Luan W, Ding Y, Ma S, Ruan H, Wang J, Lu F. Long noncoding RNA LINC00518 acts as a competing endogenous RNA to promote the metastasis of malignant melanoma via miR-204-5p\/AP1S2 axis. Cell Death Dis. 2019;10(11):855.","journal-title":"Cell Death Dis"},{"issue":"9","key":"1599_CR11","doi-asserted-by":"publisher","first-page":"16609","DOI":"10.1002\/jcp.28335","volume":"234","author":"Wenkang Luan","year":"2019","unstructured":"Luan W, Zhang X, Ruan H, Wang J, Bu X. Long noncoding RNA OIP5-AS1 acts AS a competing endogenous RNA to promote glutamine catabolism and malignant melanoma growth by sponging miR-217. J Cell Physiol. 2019. https:\/\/doi.org\/10.1002\/jcp.28335.","journal-title":"Journal of Cellular Physiology"},{"issue":"50","key":"1599_CR12","doi-asserted-by":"publisher","first-page":"81981","DOI":"10.18632\/oncotarget.11962","volume":"7","author":"Whitney S. Henry","year":"2016","unstructured":"Henry WS, Hendrickson DG, Beca F, Glass B, Lindahl-Allen M, He L, et al. LINC00520 is induced by Src, STAT3, and PI3K and plays a functional role in breast cancer. Oncotarget. 2016;7(50):81981\u201394.","journal-title":"Oncotarget"},{"issue":"2","key":"1599_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.13201\/j.issn.1001-1781.2018.18.019","volume":"32","author":"YY Wu","year":"2018","unstructured":"Wu YY, Gao W, Zhang YL, Niu M, Cui JJ, Xiang CX, et al. Expression and clinical significance of long non-coding RNA LINC00520 in laryngeal squamous cell carcinoma. Lin chuang er bi yan hou tou jing wai ke za zhi. 2018;32(2):91\u20135. https:\/\/doi.org\/10.13201\/j.issn.1001-1781.2018.18.019.","journal-title":"Lin chuang er bi yan hou tou jing wai ke za zhi"},{"key":"1599_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.gene.2019.02.093","volume":"707","author":"T Xie","year":"2019","unstructured":"Xie T, Pi G, Yang B, Ren H, Yu J, Ren Q, et al. Long non-coding RNA 520 is a negative prognostic biomarker and exhibits pro-oncogenic function in nasopharyngeal carcinoma carcinogenesis through regulation of miR-26b-3p\/USP39 axis. Gene. 2019;707:44\u201352. https:\/\/doi.org\/10.1016\/j.gene.2019.02.093.","journal-title":"Gene."},{"issue":"4","key":"1599_CR15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/CM9.0000000000000070","volume":"132","author":"XL Mei","year":"2019","unstructured":"Mei XL, Zhong S. Long noncoding RNA LINC00520 prevents the progression of cutaneous squamous cell carcinoma through the inactivation of the PI3K\/Akt signaling pathway by downregulating EGFR. Chin Med J. 2019;132(4):454\u201365. https:\/\/doi.org\/10.1097\/CM9.0000000000000070.","journal-title":"Chin Med J"},{"issue":"7483","key":"1599_CR16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344\u201352. https:\/\/doi.org\/10.1038\/nature12986.","journal-title":"Nature."},{"issue":"39","key":"1599_CR17","doi-asserted-by":"publisher","first-page":"63901","DOI":"10.18632\/oncotarget.11564","volume":"7","author":"W Luan","year":"2016","unstructured":"Luan W, Li L, Shi Y, Bu X, Xia Y, Wang J, et al. Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22. Oncotarget. 2016;7(39):63901\u201312. https:\/\/doi.org\/10.18632\/oncotarget.11564.","journal-title":"Oncotarget."},{"issue":"1","key":"1599_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1006\/geno.2000.6418","volume":"71","author":"ZA Jenkins","year":"2001","unstructured":"Jenkins ZA, Haag PG, Johansson HE. Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression. Genomics. 2001;71(1):101\u20139. https:\/\/doi.org\/10.1006\/geno.2000.6418.","journal-title":"Genomics."},{"key":"1599_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12935-015-0250-9","volume":"15","author":"Y Bao","year":"2015","unstructured":"Bao Y, Lu Y, Wang X, Feng W, Sun X, Guo H, et al. Eukaryotic translation initiation factor 5A2 (eIF5A2) regulates chemoresistance in colorectal cancer through epithelial mesenchymal transition. Cancer Cell Int. 2015;15:109.","journal-title":"Cancer Cell Int"},{"issue":"17","key":"1599_CR20","doi-asserted-by":"publisher","first-page":"24348","DOI":"10.18632\/oncotarget.8324","volume":"7","author":"RR Liu","year":"2016","unstructured":"Liu RR, Lv YS, Tang YX, Wang YF, Chen XL, Zheng XX, et al. Eukaryotic translation initiation factor 5A2 regulates the migration and invasion of hepatocellular carcinoma cells via pathways involving reactive oxygen species. Oncotarget. 2016;7(17):24348\u201360. https:\/\/doi.org\/10.18632\/oncotarget.8324.","journal-title":"Oncotarget."},{"issue":"12","key":"1599_CR21","first-page":"4269","volume":"10","author":"J Sun","year":"2018","unstructured":"Sun J, Xu Z, Lv H, Wang Y, Wang L, Ni Y, et al. eIF5A2 regulates the resistance of gastric cancer cells to cisplatin via induction of EMT. Am J Transl Res. 2018;10(12):4269\u201379.","journal-title":"Am J Transl Res"},{"issue":"7","key":"1599_CR22","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1053\/j.gastro.2014.02.029","volume":"146","author":"Y Li","year":"2014","unstructured":"Li Y, Fu L, Li JB, Qin Y, Zeng TT, Zhou J, et al. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma. Gastroenterology. 2014;146(7):1701\u201313 e9. https:\/\/doi.org\/10.1053\/j.gastro.2014.02.029.","journal-title":"Gastroenterology."},{"issue":"2","key":"1599_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/bjc.2013.688","volume":"110","author":"S Khosravi","year":"2014","unstructured":"Khosravi S, Wong RP, Ardekani GS, Zhang G, Martinka M, Ong CJ, et al. Role of EIF5A2, a downstream target of Akt, in promoting melanoma cell invasion. Br J Cancer. 2014;110(2):399\u2013408. https:\/\/doi.org\/10.1038\/bjc.2013.688.","journal-title":"Br J Cancer"},{"key":"1599_CR24","doi-asserted-by":"crossref","unstructured":"Ni X, Ding Y, Yuan H, Shao J, Yan Y, Guo R, et al. Long non-coding RNA ZEB1-AS1 promotes colon adenocarcinoma malignant progression via miR-455-3p\/PAK2 axis. Cell Proliferat. 2020;53(1):e12723.","DOI":"10.1111\/cpr.12723"},{"issue":"11","key":"1599_CR25","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1002\/cam4.1213","volume":"6","author":"H Liu","year":"2017","unstructured":"Liu H, Dai C, Wu Q, Liu H, Li F. Expression profiling of long noncoding RNA identifies lnc-MMP3-1 as a prognostic biomarker in external auditory canal squamous cell carcinoma. Cancer medicine. 2017;6(11):2541\u201351. https:\/\/doi.org\/10.1002\/cam4.1213.","journal-title":"Cancer medicine"},{"key":"1599_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-4939-1369-5_3","volume":"1206","author":"M Subramanian","year":"2015","unstructured":"Subramanian M, Li XL, Hara T, Lal A. A biochemical approach to identify direct microRNA targets. Methods Mol Biol. 2015;1206:29\u201337.","journal-title":"Methods Mol Biol"},{"issue":"15","key":"1599_CR27","doi-asserted-by":"publisher","first-page":"13006","DOI":"10.18632\/oncotarget.3514","volume":"6","author":"W Luan","year":"2015","unstructured":"Luan W, Wang Y, Chen X, Shi Y, Wang J, Zhang J, et al. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a\/c-Myc\/hnRNPA1 feedback loop. Oncotarget. 2015;6(15):13006\u201318. https:\/\/doi.org\/10.18632\/oncotarget.3514.","journal-title":"Oncotarget."},{"issue":"8","key":"1599_CR28","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/onc.2016.286","volume":"36","author":"Y Xu","year":"2017","unstructured":"Xu Y, Qin L, Sun T, Wu H, He T, Yang Z, et al. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression. Oncogene. 2017;36(8):1157\u201366. https:\/\/doi.org\/10.1038\/onc.2016.286.","journal-title":"Oncogene."},{"issue":"18","key":"1599_CR29","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1038\/onc.2013.187","volume":"33","author":"FM Davis","year":"2014","unstructured":"Davis FM, Azimi I, Faville RA, Peters AA, Jalink K, Putney JW Jr, et al. Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent. Oncogene. 2014;33(18):2307\u201316. https:\/\/doi.org\/10.1038\/onc.2013.187.","journal-title":"Oncogene."},{"issue":"12","key":"1599_CR30","doi-asserted-by":"publisher","first-page":"6411","DOI":"10.1093\/nar\/gkz278","volume":"47","author":"Y Li","year":"2019","unstructured":"Li Y, Wang L, Rivera-Serrano EE, Chen X, Lemon SM. TNRC6 proteins modulate hepatitis C virus replication by spatially regulating the binding of miR-122\/Ago2 complexes to viral RNA. Nucleic Acids Res. 2019;47(12):6411\u201324. https:\/\/doi.org\/10.1093\/nar\/gkz278.","journal-title":"Nucleic Acids Res"},{"issue":"49","key":"1599_CR31","doi-asserted-by":"publisher","first-page":"85401","DOI":"10.18632\/oncotarget.19910","volume":"8","author":"W Luan","year":"2017","unstructured":"Luan W, Li R, Liu L, Ni X, Shi Y, Xia Y, et al. Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote malignant melanoma progression by sponging miR-152-3p. Oncotarget. 2017;8(49):85401\u201314. https:\/\/doi.org\/10.18632\/oncotarget.19910.","journal-title":"Oncotarget."},{"issue":"12","key":"1599_CR32","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1158\/0008-5472.CAN-19-0910","volume":"79","author":"V Davalos","year":"2019","unstructured":"Davalos V, Esteller M. Disruption of Long noncoding RNAs targets Cancer Hallmark pathways in lung tumorigenesis. Cancer Res. 2019;79(12):3028\u201330. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-0910.","journal-title":"Cancer Res"},{"key":"1599_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12935-018-0652-6","volume":"18","author":"B Chen","year":"2018","unstructured":"Chen B, Wang C, Zhang J, Zhou Y, Hu W, Guo T. New insights into long noncoding RNAs and pseudogenes in prognosis of renal cell carcinoma. Cancer Cell Int. 2018;18:157.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"1599_CR34","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/cas.14308","volume":"111","author":"Yipeng Wang","year":"2020","unstructured":"Wang Y, Yang C, Liu X, Zheng J, Zhang F, Wang D, et al. Transcription factor AP-4 (TFAP4)-upstream ORF coding 66 aa inhibits the malignant behaviors of glioma cells by suppressing the TFAP4\/long noncoding RNA 00520\/microRNA-520f-3p feedback loop. Cancer Sci. 2020;111(3):891\u2013906.","journal-title":"Cancer Science"},{"issue":"6","key":"1599_CR35","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41419-019-1698-7","volume":"10","author":"L Liu","year":"2019","unstructured":"Liu L, Shi Y, Shi J, Wang H, Sheng Y, Jiang Q, et al. The long non-coding RNA SNHG1 promotes glioma progression by competitively binding to miR-194 to regulate PHLDA1 expression. Cell Death Dis. 2019;10(6):463.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1599_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13046-018-0945-6","volume":"37","author":"G Lu","year":"2018","unstructured":"Lu G, Li Y, Ma Y, Lu J, Chen Y, Jiang Q, et al. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p\/E2F1\/Nanog axis. J Experiment Clin Cancer Res. 2018;37(1):289.","journal-title":"J Experiment Clin Cancer Res"},{"issue":"11","key":"1599_CR37","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1158\/1541-7786.MCR-18-0284","volume":"16","author":"M Sang","year":"2018","unstructured":"Sang M, Meng L, Liu S, Ding P, Chang S, Ju Y, et al. Circular RNA ciRS-7 maintains metastatic phenotypes as a ceRNA of miR-1299 to target MMPs. Mol Cancer Res. 2018;16(11):1665\u201375. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0284.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"1599_CR38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s13577-019-00285-x","volume":"33","author":"S Liu","year":"2020","unstructured":"Liu S, Chen Q, Wang Y. MiR-125b-5p suppresses the bladder cancer progression via targeting HK2 and suppressing PI3K\/AKT pathway. Hum Cell. 2020;33(1):185\u201394. https:\/\/doi.org\/10.1007\/s13577-019-00285-x.","journal-title":"Hum Cell"},{"key":"1599_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12935-019-0919-6","volume":"19","author":"S Hua","year":"2019","unstructured":"Hua S, Quan Y, Zhan M, Liao H, Li Y, Lu L. miR-125b-5p inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma via targeting TXNRD1. Cancer Cell Int. 2019;19:203.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"1599_CR40","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.3892\/ol.2019.10506","volume":"18","author":"J Yan","year":"2019","unstructured":"Yan J, Jiang Q, Lu H, Na S, Long S, Xin Y, et al. Association between microRNA-125b expression in formalin-fixed paraffin-embedded tumor tissues and prognosis in patients with melanoma. Oncol Lett. 2019;18(2):1856\u201362. https:\/\/doi.org\/10.3892\/ol.2019.10506.","journal-title":"Oncol Lett"},{"issue":"3","key":"1599_CR41","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/ced.12286","volume":"39","author":"J Zhang","year":"2014","unstructured":"Zhang J, Lu L, Xiong Y, Qin W, Zhang Y, Qian Y, et al. MLK3 promotes melanoma proliferation and invasion and is a target of microRNA-125b. Clin Exp Dermatol. 2014;39(3):376\u201384. https:\/\/doi.org\/10.1111\/ced.12286.","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"1599_CR42","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.18632\/oncotarget.6599","volume":"7","author":"E Vergani","year":"2016","unstructured":"Vergani E, Di Guardo L, Dugo M, Rigoletto S, Tragni G, Ruggeri R, et al. Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b. Oncotarget. 2016;7(4):4428\u201341. https:\/\/doi.org\/10.18632\/oncotarget.6599.","journal-title":"Oncotarget."},{"issue":"1","key":"1599_CR43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13058-016-0740-2","volume":"18","author":"KM Bussard","year":"2016","unstructured":"Bussard KM, Mutkus L, Stumpf K, Gomez-Manzano C, Marini FC. Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast cancer research : BCR. 2016;18(1):84.","journal-title":"Breast cancer research : BCR"},{"issue":"12","key":"1599_CR44","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.1158\/0008-5472.CAN-03-3747","volume":"64","author":"XY Guan","year":"2004","unstructured":"Guan XY, Fung JM, Ma NF, Lau SH, Tai LS, Xie D, et al. Oncogenic role of eIF-5A2 in the development of ovarian cancer. Cancer Res. 2004;64(12):4197\u2013200. https:\/\/doi.org\/10.1158\/0008-5472.CAN-03-3747.","journal-title":"Cancer Res"},{"issue":"3","key":"1599_CR45","doi-asserted-by":"publisher","first-page":"e0119229","DOI":"10.1371\/journal.pone.0119229","volume":"10","author":"QB Meng","year":"2015","unstructured":"Meng QB, Kang WM, Yu JC, Liu YQ, Ma ZQ, Zhou L, et al. Overexpression of eukaryotic translation initiation factor 5A2 (EIF5A2) correlates with cell aggressiveness and poor survival in gastric cancer. PLoS One. 2015;10(3):e0119229. https:\/\/doi.org\/10.1371\/journal.pone.0119229.","journal-title":"PLoS One"},{"issue":"12","key":"1599_CR46","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1172\/JCI98060","volume":"128","author":"V Huber","year":"2018","unstructured":"Huber V, Vallacchi V, Fleming V, Hu X, Cova A, Dugo M, et al. Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma. J Clin Invest. 2018;128(12):5505\u201316. https:\/\/doi.org\/10.1172\/JCI98060.","journal-title":"J Clin Invest"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-020-01599-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-020-01599-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-020-01599-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:39:49Z","timestamp":1622162389000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-020-01599-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1599"],"URL":"https:\/\/doi.org\/10.1186\/s13046-020-01599-7","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,28]]},"assertion":[{"value":"13 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki principles. It was approved by the Ethics Committee of the Affiliated People\u2019s Hospital of Jiangsu University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}